Viveve stock crashes ~60% as company decides to delist, explore sale after trial fails

Modern Medicine Research Laboratory: Diverse Team of Multi-Ethnic Young Scientists Passes Samples in Petri Dish. Advanced Lab with High-Tech Equipment, Microbiology Researchers Design, Develop Drugs


Viveve Medical (NASDAQ:VIVE) remedy for feminine stress urinary incontinence (SUI) failed a pivotal trial and the company has determined to search strategic options and delist from Nasdaq.

The Englewood, Colo.-based company added that due to its enterprise prospects following

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!